Today: 29 April 2026
Browse Category

NASDAQ:MRNA 28 September 2025 - 6 November 2025

Stocks Slip as Tech Wobble Returns; Layoffs Spike and Tariff Showdown Clouds Outlook — Stock Market Today (Nov. 6, 2025)

Stocks Slip as Tech Wobble Returns; Layoffs Spike and Tariff Showdown Clouds Outlook — Stock Market Today (Nov. 6, 2025)

U.S. stocks opened lower Thursday as investors weighed weak private jobs data and mixed earnings. Challenger reported over 150,000 announced layoffs in October, the highest for the month in more than 20 years. The dollar fell for a second day as traders raised odds of a December Fed rate cut. Qualcomm and DoorDash dropped on company risks; Datadog and Moderna gained on strong results.
6 November 2025
······
Moderna (MRNA) Beats Q3 on Sales of New COVID Shot, Trims 2025 Outlook; Stock Whipsaws — Nov. 6, 2025

Moderna (MRNA) Beats Q3 on Sales of New COVID Shot, Trims 2025 Outlook; Stock Whipsaws — Nov. 6, 2025

Moderna reported Q3 2025 revenue of $1.02 billion and a GAAP loss of $0.51 per share, both ahead of analyst forecasts, driven by $971 million in COVID-19 vaccine sales. The company narrowed its full-year revenue outlook to $1.6–$2.0 billion, cut operating-expense guidance by $700 million, and raised its year-end cash target. Shares rose pre-market but traded unevenly during the session.
6 November 2025
··
Nasdaq Rally Amid Tech Frenzy: Markets Brush Off Shutdown Fears in Late September 2025

U.S. Stock Market Today (Nov. 6, 2025): Futures Mixed as Jobless Claims & Productivity Loom; Tesla Pay Vote, Airbnb & DraftKings Earnings in Focus

U.S. equity futures edged lower early Thursday as Asian markets rebounded on strong U.S. data, while European shares slipped. Treasury yields rose and the dollar stayed firm. Key U.S. data releases include jobless claims and productivity at 8:30 a.m. ET. Qualcomm, Arm, and Snap moved pre-market on earnings, with several major reports due before and after the bell.
6 November 2025
········
Moderna Stock Soars on Buyout Buzz – Can New Vaccines Fuel a Comeback?

Moderna Stock Soars on Buyout Buzz – Can New Vaccines Fuel a Comeback?

Moderna shares surged 12% to near $27.50 on Oct. 30, 2025, after reports of takeover talks with a large drugmaker. The rally follows a STAT News report on possible deals, but Moderna declined comment. Despite gains, the stock remains down about 37% year-to-date. Recent FDA approvals include updated COVID and RSV vaccines, but falling COVID demand has cut 2025 revenue and forced cost reductions.
30 October 2025
··
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 19.10.2025

China blocked Ant Group and JD.com from launching stablecoins, reinforcing state control over digital currency. U.S. stock futures rose ahead of a packed earnings week, with Tesla and Netflix among companies reporting. IonQ reported Q3 revenue up 102% to $12.4 million but posted a $52.5 million net loss, while Nvidia posted record Q3 revenue of $35.1 billion.
19 October 2025
···········
Moderna’s Wild Ride: Vaccine Hopes Fuel Stock Pop Amid “One-Hit Wonder” Fears

Moderna’s Wild Ride: Vaccine Hopes Fuel Stock Pop Amid “One-Hit Wonder” Fears

Moderna shares rose 5% to $28 but remain down 35% in 2024 and nearly 80% below last year’s level. COVID vaccine sales have collapsed from $18.9 billion in 2022 to $3.1 billion, and Q2 revenue fell 41% to $142 million. The company cut its 2025 revenue forecast and is laying off 10% of staff. Early data from an experimental cancer vaccine showed a 24% tumor response rate in advanced melanoma.
16 October 2025
··
Moderna, Inc. (MRNA) Stock Update – Oct 8 2025: Will the mRNA Trailblazer Bounce Back or Sink Further?

Moderna, Inc. (MRNA) Stock Update – Oct 8 2025: Will the mRNA Trailblazer Bounce Back or Sink Further?

Moderna closed at $27.34 on Oct 7, 2025, with a market cap near $11 billion. Q2 revenue fell 41% year-over-year to $142 million, and the company posted a net loss of $0.8 billion. U.S. and EU regulators limited updated COVID booster use, narrowing near-term revenue prospects. Analysts’ 12-month price targets remain high, but sales forecasts have repeatedly missed expectations.
8 October 2025
··
Billion-Dollar AI Bets and Biotech Breakthroughs: Top Tech News (Sept 27–28, 2025)

Billion-Dollar AI Bets and Biotech Breakthroughs: Top Tech News (Sept 27–28, 2025)

Nvidia will invest up to $100 billion to build 10 gigawatts of AI data centers for OpenAI, with the first 1 GW due by late 2026. The US cybersecurity agency issued an emergency directive after hackers breached at least one federal agency via Cisco firewall flaws, affecting hundreds of devices. The FDA approved Eli Lilly’s new breast cancer drug Inluriyo. The SEC loosened ETF rules, opening the door for new crypto ETFs.
28 September 2025
·········
1 2 3

Stock Market Today

  • Donegal Group (DGICA) Ex-Dividend Date Set for May 1, 2026
    April 29, 2026, 11:01 AM EDT. Donegal Group Inc. (DGICA) will trade ex-dividend on May 1, 2026, with a quarterly payout of $0.1925, equating to about 1.08% yield based on the recent price of $17.86. The dividend is payable on May 15, 2026. DGICA shares closed near $17.83, within a 52-week range of $16.43 to $21.12. The stock currently offers an annualized yield of approximately 4.31%. Investors should note shares typically drop by the dividend amount on the ex-dividend date. In recent trading, DGICA stock fell 0.8% amid broader market moves. This ex-dividend event highlights potential income opportunities for dividend-focused investors.

Latest article

Vertiv Just Bought A Liquid-Cooling Specialist As AI Data Centers Turn Up The Heat

Vertiv Just Bought A Liquid-Cooling Specialist As AI Data Centers Turn Up The Heat

29 April 2026
Vertiv Holdings Co acquired Strategic Thermal Labs, a Texas-based liquid-cooling specialist, to boost its AI and high-performance computing data center offerings. Vertiv shares rose 0.6% to $307.00, valuing the company at about $119.9 billion. Deal terms were not disclosed. The move follows a 30% jump in Vertiv’s first-quarter net sales and an increased 2026 earnings forecast.
NIO Stock Jumps After Onvo L80 Debut: New SUV Puts China EV Maker Back in the Fight

NIO Stock Jumps After Onvo L80 Debut: New SUV Puts China EV Maker Back in the Fight

29 April 2026
NIO’s Hong Kong shares rose 8.7% after its Onvo unit began pre-sales for the L80 large electric SUV, starting at 245,800 yuan or 159,800 yuan with battery leasing. The launch follows NIO’s first quarterly net profit and aims at boosting volume in China’s crowded EV market. Test drives begin May 1, with the official launch set for May 15.
Enphase Energy, Inc. Stock Slides as Q1 Reveals a Solar Demand Hangover

Enphase Energy, Inc. Stock Slides as Q1 Reveals a Solar Demand Hangover

29 April 2026
Enphase Energy shares dropped 7.3% to $31.80 after reporting a first-quarter revenue decline to $282.9 million and a GAAP loss of $7.4 million. U.S. revenue fell 23% from the prior quarter, with sell-through demand down 48% sequentially. Adjusted earnings beat estimates, but investors appeared unconvinced demand had stabilized. SolarEdge and Sunrun shares also fell in early trading.
Go toTop